| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/14/2013 | US20130065866 Dentinal drug delivery composition and screening method |
| 03/14/2013 | US20130065844 Compositions of Stable Tiacumicins |
| 03/14/2013 | US20130064965 Implants for administering substances and methods of producing implants |
| 03/14/2013 | US20130064894 Novel cationic lipids and methods of use thereof |
| 03/14/2013 | US20130064877 Composition for the transdermal delivery of fentanyl |
| 03/14/2013 | US20130064875 Composition for enhancing transdermal absorption of a drug and patch preparation |
| 03/14/2013 | US20130064874 Method for producing orally administrable edible agent of aggregated substance-containing laminate film form and orally administrable edible agent of aggregated substance-containing laminate film form |
| 03/14/2013 | US20130064869 Composition for enhancing transdermal absorption of a drug and patch preparation |
| 03/14/2013 | US20130064868 Composition for enhancing transdermal absorption of a drug and patch preparation |
| 03/14/2013 | US20130064861 Compositions and methods for modifying in vivo calcification of hydrogels |
| 03/14/2013 | US20130064848 Heterochain aliphatic poly-n-oxide copolymers and vaccinating agents and drugs based thereon |
| 03/14/2013 | US20130064785 Skin treatment composition |
| 03/14/2013 | US20130064761 Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof |
| 03/14/2013 | CA2849448A1 Oral delivery for hemoglobin based oxygen carriers |
| 03/14/2013 | CA2849423A1 Silicone coated implants |
| 03/14/2013 | CA2848142A1 Hydrogels with biodegradable crosslinking |
| 03/14/2013 | CA2848118A1 Endostatin mutants with mutations at atp binding sites |
| 03/14/2013 | CA2847907A1 Nanoparticle tumour vaccines |
| 03/14/2013 | CA2847837A1 A pharmaceutical composition for treating cancer, comprising interferon alpha conjugate |
| 03/14/2013 | CA2847555A1 Materials and methods for modulating immune responses |
| 03/14/2013 | CA2847114A1 Method for manufacturing block copolymer |
| 03/14/2013 | CA2846898A1 Retinal cyclodextrin acetals and hemiacetals for clarifying skin complexion |
| 03/14/2013 | CA2838289A1 Sustained release formulations for delivery of proteins to the eye and methods of preparing same |
| 03/13/2013 | EP2567952A1 Cationic lipid |
| 03/13/2013 | EP2567951A1 Cationic lipid |
| 03/13/2013 | EP2567710A1 Aqueous pharmaceutical system for the administration of drugs to the nails |
| 03/13/2013 | EP2567705A2 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 03/13/2013 | EP2567700A1 Vitamin-containing nutrition infusion for administration through peripheral vein |
| 03/13/2013 | EP2567691A1 Aqueous compositions comprising arbekacin |
| 03/13/2013 | EP2567690A1 The use of amisulpride as an anti-emetic |
| 03/13/2013 | EP2567689A1 Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid |
| 03/13/2013 | EP2567618A1 Pharmaceutical composition containing an N-phenylpyrazole derivative, use for the preparation of a topical veterinary drug for flea control |
| 03/13/2013 | EP2566881A1 Peptide derivatives for biofunctionalization of silicon substrates and their applications |
| 03/13/2013 | EP2566878A1 Methods of inhibiting inflammation and inflammatory diseases using gal-3bp (btbd17b, lgals3bp, galectin-3 binding protein, mac-2 binding protein) |
| 03/13/2013 | EP2566510A1 Compositions and methods useful for reducing the viscosity of protein-containing formulations |
| 03/13/2013 | EP2566504A2 New emd formulation comprising pga |
| 03/13/2013 | EP2566503A1 Therapeutic peptide composition and method |
| 03/13/2013 | EP2566501A2 Method and device for transdermal delivery of parathyroid hormone using a microprojection array |
| 03/13/2013 | EP2566494A2 Cxcr4 receptor compounds |
| 03/13/2013 | EP2566487A1 Ophthalmic composition |
| 03/13/2013 | EP2566474A2 Non-aqueous taxane pro-emulsion formulations and methods of making and using the same |
| 03/13/2013 | EP2566458A2 Pharmaceutical formulations compising cefuroxime axetil |
| 03/13/2013 | EP2566457A1 Topical pharmaceutical composition comprising heparin |
| 03/13/2013 | EP2566456A2 Triamcinolone acetonide formulations for treating dermatitis and psoriasis |
| 03/13/2013 | EP2566454A1 Chitosan composition |
| 03/13/2013 | EP2566453A1 Novel ophthalmic compositions |
| 03/13/2013 | EP2566445A1 Novel self-reversible reverse latex, and use thereof as a thickening agent in a cosmetic composition |
| 03/13/2013 | EP2566335A1 Controlled release from macromolecular conjugates |
| 03/13/2013 | EP2566334A1 Controlled drug release from solid supports |
| 03/13/2013 | EP2566331A1 Pharmaceutical compositions and methods of making same |
| 03/13/2013 | EP2566325A1 Compositions of small molecule therapeutics |
| 03/13/2013 | EP2407536A9 ADP-ribosyl transferase fusion variant proteins |
| 03/13/2013 | CN102971013A Conjugated blood coagulation factor VIIa |
| 03/13/2013 | CN102971006A Stabilized factor VIII variants |
| 03/13/2013 | CN102971002A Composition for nucleic acid delivery, carrier composition, pharmaceutical composition using the composition for nucleic acid delivery or the carrier composition, and method for delivering nucleic acid |
| 03/13/2013 | CN102970987A Methods of delivering a health care active by administering personal health care articles comprising a filament |
| 03/13/2013 | CN102970985A Controlled-release pharmaceutical composition including tamsulosin or the pharmaceutically acceptable salts thereof, and oral preparation including same |
| 03/13/2013 | CN102970982A Enteric tablet |
| 03/13/2013 | CN102970975A Method for preparing an enriched IgG composition from plasma |
| 03/13/2013 | CN102970974A Triamcinolone acetonide formulations for treating dermatitis and psoriasis |
| 03/13/2013 | CN102970973A Novel ophthalmic compositions |
| 03/13/2013 | CN102970971A Mesalamine suppository |
| 03/13/2013 | CN102964593A Block polymer, preparation method thereof and electrically active hydrogel |
| 03/13/2013 | CN102964591A Preparation method of polyamino acid segmented copolymer and polyamino acid segmented copolymer hydrogel |
| 03/13/2013 | CN102964588A Preparation method and application of acid or active ester of polyethylene glycol with tail end connected with aminophenyl propionic acid |
| 03/13/2013 | CN102964587A Preparation method and application of acid or active ester of polyethylene glycol with tail end connected with proline |
| 03/13/2013 | CN102964442A Method for preparing polyethylene glycol (PEG) and nerve growth factor (NGF) conjugate |
| 03/13/2013 | CN102964347A 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 03/13/2013 | CN102961785A Tumor cavity filler for treating giant cell tumor of bone and preparation method thereof |
| 03/13/2013 | CN102961759A Targeting gene transferring method of folic acid-functionalized PAMAM (polyamidoamine dendrimers) wrapped by gold nanoparticles |
| 03/13/2013 | CN102961756A Synthesis method of polypeptide-nanogold particle drug carrier |
| 03/13/2013 | CN102961755A Ligand-functioned super-molecular nano-drug delivery system for treating tumor |
| 03/13/2013 | CN102961754A Beta-cyclodextrin calcium carbonate microsphere drug loading system as well as preparation method and application thereof |
| 03/13/2013 | CN102961753A Copper sulfide/mesoporous silicon dioxide core-shell nano material as well as preparation method and application thereof |
| 03/13/2013 | CN102961752A Functional auxiliary material as well as preparation method and application thereof |
| 03/13/2013 | CN102961751A Composition for improving oral bioavailability of alkaloid and preparation method |
| 03/13/2013 | CN102961750A Application of silicon dioxide aerogel in pharmacy |
| 03/13/2013 | CN102961748A Method for reducing intraocular pressure by using gap junction blocker |
| 03/13/2013 | CN102961713A Ginger and garlic enteric-coated tablet and preparation method thereof |
| 03/13/2013 | CN102961558A Patch and preparation method thereof |
| 03/13/2013 | CN102961479A Plastics for promoting healing of skin wound and preparation method of plastics |
| 03/13/2013 | CN102961469A Traditional Chinese medicine dispersible tablet for treating upper respiratory infection, and preparation method and quality detection method thereof |
| 03/13/2013 | CN102961432A Patch for treating deafness and tinnitus and preparation method thereof |
| 03/13/2013 | CN102961399A Sodium chloride eye drops and preparation method thereof |
| 03/13/2013 | CN102961397A Pharmaceutical composition of fat emulsion injection and compound amino acid injection |
| 03/13/2013 | CN102961371A Ibuprofen arginine granule and preparation method thereof |
| 03/13/2013 | CN102961368A Curcumin nanosuspension and preparation method thereof |
| 03/13/2013 | CN102961365A Terbutaline sulfate oral instant film and preparation method thereof |
| 03/13/2013 | CN102961364A Sensitive and color-changing anti-acne repairing diaphragm |
| 03/13/2013 | CN102961362A Beta-poly malic acid/chitosan nano drug sustained-release microcapsule and preparation method thereof |
| 03/13/2013 | CN102961360A Oxymatrine hepatic targeting nano drug delivery system and preparation method thereof |
| 03/13/2013 | CN102961358A Abiraterone acetate liquid capsule |
| 03/13/2013 | CN102961357A Safflower carthamus uranidin effervescent tablets and preparation technology thereof |
| 03/13/2013 | CN102961355A Clopidogrel hydrogen sulfate tablet and preparation method thereof |
| 03/13/2013 | CN102961354A Acemetacin three-layer controlled release tablet and preparation method thereof |
| 03/13/2013 | CN102961353A Glipizide sustained-release dropping pill for treating diabetes and preparation method thereof |
| 03/13/2013 | CN102961352A Preparation method of doxazosin mesylate sustained-release dropping pill for treating hypertension and prostatic hyperplasia |
| 03/13/2013 | CN102961351A Dihydrocodeine tartrate sustained-release dropping pill and preparation method thereof |
| 03/13/2013 | CN102961350A Carbidopa-levedopa sustained-release dropping pill and preparation method thereof |
| 03/13/2013 | CN102961349A Acetaminophen sustained-release dropping pill and preparation method thereof |